 Determination growth fraction advanced prostate cancer immunostaining relationship time progression hormonal therapy Reliable predictors response prostate cancer patients undergoing hormonal therapy study possibility tumor proliferation rates tumor behavior patients growth fraction metastatic prostate cancer biopsy specimens androgen withdrawal therapy antibody immunohistochemical study tumor growth fraction time progression therapy percentage malignant epithelial nuclei primary tumors patients median patients response groups median time progression poor responders time progression months good responders equal months similar growth fractions versus nuclei patients groups median growth fraction patients high growth fraction nuclei time progression median months patients low growth fraction median time progression months statistical significance interesting trend immunostaining accurate time progression individual patients undergoing hormonal therapy Reliable prediction growth rates measurement cell proliferation cell death rates